Invesco S&P Midcap 400 Pure Growth ETF
RFGNYSEARCAInvescoEquity
As of Oct 16, 2026 close
- Assets (AUM)
- $332.12M
- Expense ratio
- 0.35%
- Dividend yield
- 0.11%
- Holdings
- 103
- 52-week range
- $49.50$64.81
- Volume (live)
- -
- Avg. volume (3M)
- 8.94K
RFG ETF: Invesco S&P Midcap 400 Pure Growth ETF - Price, Holdings & Analysis
Invesco S&P Midcap 400 Pure Growth ETF Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fund characteristics, expense ratio, dividend yield, and performance metrics
| Day's Range | $57.20 - $58.39 |
|---|---|
| 52-Week High | $64.81 |
| 52-Week Low | $49.50 |
| Open | $58.38 |
| Volume (last close) | 14.65K |
| Average Volume (3M) | 8.94K |
| 1 Day Change | +0.71% |
|---|---|
| 1 Month Change | −0.78% |
| 6 Month Change | −2.65% |
| YTD Change | +9.51% |
| 1 Year Change | +16.64% |
| 5 Year Change | +29.03% |
| 10 Year Change | +140.23% |
| Annual Dividend | $0.06 |
|---|---|
| Dividend Yield | 0.11% |
| Last Dividend Ex-Date | Sep 21, 2026 |
| Dividend Growth YoY | −71.29% |
| Assets (AUM) | $332.12M |
|---|---|
| Expense Ratio | 0.35% |
| Total Holdings | 103 |
| Inception Date | Feb 28, 2006 |
| 50-Day MA | $60.72 |
|---|---|
| 200-Day MA | $59.37 |
| RSI | 37.65 |
| Stochastic %K | 5.74 |
| Stochastic %D | 23.06 |
Source: Exchange price data and fund disclosures. Data as of Oct 16, 2026. Data sources and methodology
RFG at a Glance
Invesco S&P Midcap 400 Pure Growth ETF (RFG) is an equity ETF from Invesco, launched in February 2006. It manages $332.12M in assets and charges a 0.35% expense ratio, about $35 a year per $10,000 invested.
As of its Oct 4, 2026 holdings, it holds 103 positions. The largest are Halozyme Therapeutics, Inc. (HALO, 2.72%), Arrowhead Pharmaceuticals, Inc (ARWR, 2.45%) and TechnipFMC plc (FTI, 2.31%). The top 10 holdings make up 21.8% of the fund. By sector it leans toward Industrials (25.3%), Healthcare (24.4%) and Technology (23.8%). 95.9% of assets are in the United States.
It pays distributions yielding 0.11% at the Oct 16, 2026 close, $0.06 per share over the trailing 12 months. As of the Oct 16, 2026 close, the share price is up 16.6% over one year, up 29.0% over five years and up 140.2% over ten years (price change, excluding distributions).
Frequently Asked Questions About Invesco S&P Midcap 400 Pure Growth ETF
What is the current price of RFG?
The latest RFG price is $57.23 (Oct 16, 2026 close). The 52-week range is $49.50–$64.81. The share price is up 16.6% over the past year (price change, excluding distributions).
What is the expense ratio for RFG?
RFG's annual expense ratio is 0.35%. This represents the yearly cost of holding the fund, deducted from total returns. Compare with similar Equity ETFs in the ETF Screener.
Does RFG pay dividends?
Yes, RFG pays a 0.11% dividend yield (trailing 12 months, at the Oct 16, 2026 close). The most recent ex-dividend date was September 21, 2026. View full dividend history in the Dividends section.
What are the top holdings of RFG?
As of Oct 4, 2026, RFG's largest holdings are Halozyme Therapeutics, Inc. (2.7%), Arrowhead Pharmaceuticals, Inc (2.4%), TechnipFMC plc (2.3%) (combined weight: 7.5%). The fund holds 103 total positions. View the complete portfolio breakdown in the Holdings section.
How does RFG compare to similar ETFs?
Compare RFG (0.35% expense ratio, $332M AUM) against similar Equity ETFs using the ETF Screener. Filter by expense ratio, dividend yield, and performance to find alternatives.